cGxP.wire https://validator.w3.org/feed/docs/rss2.html Allucent Launches IGNITE™ to Accelerate Clinical Trials Sanofi Nexviazyme Delivers Positive Phase 3 Pompe Trial Results Zambon Hopledo® Wins CHMP Backing for Parkinson’s Disease Palisade Bio Receives FDA IND Clearance for PALI-2108 Anixa Wins First Korean Patent for Breast Cancer Vaccine Biodexa Expands Phase 3 Serenta Trial into Canada for FAP Roche Enspryng Gains FDA Priority Review for TED Treatment Pfizer Canada Secures PADCEV Plus KEYTRUDA Approval CraniUS Secures NIH Grant for Glioblastoma Therapy AbbVie RINVOQ® Moves Closer to EU Approval for Alopecia Areata Orion Pharma Expands Europe Biosimilar Portfolio with Shilpa Silo Pharma Advances SPC-15 PTSD Program Toward FDA Meeting Genmab Phase 3 Epcoritamab Trial Meets Primary PFS Endpoint Aurenar Wins FDA Breakthrough Device Status for V-Link™ Abivax Reports Positive Phase 3 Obefazimod Maintenance Data Gain Therapeutics Wins FDA IND Clearance for GT-02287 Bioness Medical Secures FDA 510(k) Clearance for PoNS® AGC Biologics Partners with Pyramid for U.S. Fill-Finish Services Aspen Neuroscience Completes Cohort 4 in ASPIRO Parkinson’s Trial DBV Technologies Works With FDA to Finalize VIASKIN Peanut BLA Renalytix KidneyIntelX® Delivers Strong Two-Year DKD Outcomes Praxis Precision Medicines Extends FDA Review for Relutrigine NDA Arcutis Secures FDA Approval for ZORYVE in Children Aged 2+ ADC Therapeutics Advances ZYNLONTA® in LOTIS-7 Lymphoma Trial Genentech Wins FDA Priority Review for Enspryng in Thyroid Eye Disease BillionToOne Northstar Response® Advances Cancer Monitoring Inductive Bio Brings AI-Powered ADMET Models to Claude AbbVie Reports Positive Phase 3 Epcoritamab DLBCL Results FDA Selects Seven Firms for PreCheck Manufacturing Pilot DarioHealth and Beluga Partner to Transform Digital Chronic Care 4DMedical Unlocks Advanced CT:VQ Imaging for Australia Terumo Completes First U.S. OPUSWAVE Imaging Procedure Artivion Brings FDA-Approved AMDS to U.S. Heart Centers Zymeworks Acquires Theravance to Expand Healthcare Portfolio SetPoint Medical Delivers First FDA-Approved RA Device in N.C. Daiichi Sankyo and AstraZeneca Secure EU Enhertu Approval Ipsen and Kartos Therapeutics Sign $1.75B Acquisition Deal Samsung Bioepis Reports Positive SB27 Keytruda Biosimilar Results Nuvation Bio Secures UK Review for Taletrectinib Talawar Therapeutics to Go Public in JATT II Merger REGENXBIO Doses First Patient in NAAVIGATE Gene Trial Eisai Showcases Alzheimer’s Research at AAIC 2026 Meeting PharmaEssentia Secures FDA Approval for BESREMi Pen in Polycythemia Vera Nippon Shinyaku, Elixirgen Sign EXG-7001 DMD Option Deal OS Animal Health Shows Positive Phase 2 Results for OST-HER2 Acadia’s DAYBU Recommended for EU Approval in Rett Syndrome Capricor Reaches Key FDA Milestone in DMD Curis Reaffirms Initial Patient Dosing Timeline for TakeAim CLL Trial Epicrispr Advances Epigenetic Therapy With Promising FSHD Clinical Data Star Therapeutics to Present Phase 1/2 VGA039 Data at ISTH 2026